BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21737657)

  • 21. [Clinical investigation of bisphosphonate-related osteonecrosis of the jaws].
    Dehari H; Tomihara K; Ueda M; Shimanishi M; Ono M; Sasaki T; Igarashi T; Shiratori K; Abe M; Ogi K; Nakamori K; Miyazaki A; Nagai I; Hiratsuka H
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2587-92. PubMed ID: 20009460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw.
    Hoefert S; Eufinger H
    J Oral Maxillofac Surg; 2011 Feb; 69(2):362-80. PubMed ID: 21122968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results.
    Romeo U; Galanakis A; Marias C; Vecchio AD; Tenore G; Palaia G; Vescovi P; Polimeni A
    Photomed Laser Surg; 2011 Jul; 29(7):447-52. PubMed ID: 21235406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dental management of patients with a history of bisphosphonate therapy: clinical dilemma.
    Migliorati CA; Hsu CJ; Chopra S; Kaltman SS
    J Calif Dent Assoc; 2008 Oct; 36(10):769-74. PubMed ID: 19044097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT; Chiang WF; Chuang CY; Chang SW
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
    Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review.
    Hewitt C; Farah CS
    J Oral Pathol Med; 2007 Jul; 36(6):319-28. PubMed ID: 17559492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I; Magopoulos C; Karakasis D
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.
    Rugani P; Acham S; Truschnegg A; Obermayer-Pietsch B; Jakse N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e1-6. PubMed ID: 21112522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates.
    Thumbigere-Math V; Tu L; Huckabay S; Dudek AZ; Lunos S; Basi DL; Hughes PJ; Leach JW; Swenson KK; Gopalakrishnan R
    Am J Clin Oncol; 2012 Aug; 35(4):386-92. PubMed ID: 22561331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
    J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bisphosphonate-related osteonecrosis of the jaw].
    Franken AA; van Blijderveen NJ; Witjes MJ; Netelenbos CJ
    Ned Tijdschr Geneeskd; 2011; 155():A3077. PubMed ID: 21486510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
    Sarasquete ME; González M; San Miguel JF; García-Sanz R
    Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bisphosphonate-associated osteonecrosis of the jaws. 2. Six case reports].
    Kicken M; Van Cann EM; Koole R
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):428-31. PubMed ID: 17972611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis.
    Manfredi M; Merigo E; Guidotti R; Meleti M; Vescovi P
    Int J Oral Maxillofac Surg; 2011 Mar; 40(3):277-84. PubMed ID: 21163625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
    Brown JJ; Ramalingam L; Zacharin MR
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.
    Scoletta M; Arduino PG; Dalmasso P; Broccoletti R; Mozzati M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):46-53. PubMed ID: 20452252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.
    Pautke C; Bauer F; Otto S; Tischer T; Steiner T; Weitz J; Kreutzer K; Hohlweg-Majert B; Wolff KD; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum SR; Kolk A
    J Oral Maxillofac Surg; 2011 Jan; 69(1):84-91. PubMed ID: 20971542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.